Check with your provider or pharmacist before trying a new medication, especially if symptoms are worsening or don't improve
Sensitivity and specificity of handheld fundus cameras for eye disease: a systematic review and pooled analysis
Efficacy and Safety of Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, in People with Type 2 Diabetes and Inadequate Glycaemic Control with Diet and Exercise (TRANSCEND-T2D-1): A Double-Blind, Randomised, Phase 3 Trial
This approach means changing vials as you titrate, which some people find inconvenient
Both support once-weekly administration in their respective trial programs
If you suspect your symptoms are related to tirzepatide, you can report possible side effects directly to the MHRA through the Yellow Card Scheme at yellowcard